During the past decade, Northwestern Univ / Div of Infect Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Northwestern Univ / Div of Infect Diseases" are "HIV Infections" (3 trials), "Acquired Immunodeficiency Syndrome" (1 trials) and "HIV I Infection" (1 trials). Many other conditions were trialed in "Northwestern Univ / Div of Infect Diseases" in a lesser frequency.

Most popular intervention types in "Northwestern Univ / Div of Infect Diseases" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (1 trials), "FTC/TDF" (1 trials), "Indinavir sulfate" (1 trials), "Lamivudine" (1 trials) and "Nelfinavir mesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern Univ / Div of Infect Diseases" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Northwestern Univ / Div of Infect Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Northwestern Univ / Div of Infect Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern Univ / Div of Infect Diseases, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".